➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
AstraZeneca
Medtronic
Dow
Johnson and Johnson

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drug Price Trends for NAPROXEN


Email this page to a colleague

« Back to Dashboard

Drug Price Trends for NAPROXEN

Average Pharmacy Cost for NAPROXEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NAPROXEN 500 MG TABLET 76282-0342-05 0.07779 EACH 2021-05-19
NAPROXEN 500 MG TABLET 76282-0342-01 0.07779 EACH 2021-05-19
NAPROXEN 375 MG TABLET 76282-0341-05 0.08079 EACH 2021-05-19
NAPROXEN 375 MG TABLET 76282-0341-01 0.08079 EACH 2021-05-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NAPROXEN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NAPROXEN NA 550MG TAB Sterisyn Inc. 50228-0433-01 100 42.49 0.42490 EACH 2021-04-05 - 2024-04-17 FSS
NAPROXEN NA 550MG TAB Sterisyn Inc. 50228-0433-05 500 212.45 0.42490 EACH 2021-04-05 - 2024-04-17 FSS
NAPROXEN NA 275MG TAB Sterisyn Inc. 50228-0432-01 100 17.95 0.17950 EACH 2021-04-05 - 2024-04-17 FSS
NAPROXEN NA 220MG TAB Major Pharmaceuticals 00536-1093-01 100 4.54 0.04540 EACH 2018-12-01 - 2023-11-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Colorcon
AstraZeneca
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.